NASH FibroSure Plus NASHFIBRO

Synonyms

Allscripts (AEHR) Order Name

NASH FibroSure Plus

Sunrise Clinical Manager (SCM) Order Name

NASH FibroSure Plus

EPIC Order Name

NASH FibroSure Plus

Clinical Info

This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD).
Limitations NASH FibroSure® is recommended for patients with suspected nonalcoholic fatty liver disease. It is not recommended for patient with other 
liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, autoimmune 
hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative
 predictions of fibrosis.

Specimen Type

Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube: Red or Gold top tube
Specimen: 3.5 mL serum ( 2 mL min)
Transport Temperature: Refrigerated

Note: Patient should be fasting for at least eight hours
Causes for Rejection
Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age

Transport Instructions

Refrigerated

Specimen Stability

3 Days Room Temperature or Refrigerated
7 Days Frozen

.

Methodology

The analytes tested are
performed by FibroSure-Specific methods.

Days Performed

Performing Laboratory

LabCorp

CPT

82172; 82247; 82465; 82947; 82977; 83010;
83883;  84450;  84460;  84478

PDM

1559233

Result Interpretation

See Report

Forms